Nuvalent, Inc. (NUVL)
105.80
+0.06
(+0.06%)
USD |
NASDAQ |
Dec 11, 16:00
105.80
0.00 (0.00%)
After-Hours: 20:00
Nuvalent Free Cash Flow: -263.88M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp. | 3.824B |
| Pfizer Inc. | 10.38B |
| Xencor, Inc. | -137.94M |
| Glaukos Corp. | -27.61M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -70.46M |
| Cash from Investing (Quarterly) | 53.97M |
| Cash from Financing (Quarterly) | 4.773M |
| Free Cash Flow Per Share (Quarterly) | -0.9767 |
| Free Cash Flow to Equity (Quarterly) | -70.46M |
| Free Cash Flow to Firm (Quarterly) | -70.46M |
| Free Cash Flow Yield | -3.48% |